Novel radioligand binding assay for accurate determination of retinoid X receptors binding capabilities.
Optimal conditions for 9-cis retinoic acid specific binding to its cognate nuclear retinoid X receptors.
Endocrine disruptors trialkyltin and triphenyltin have been confirmed as RXR ligands by radioligand binding assay.